Icrest Biotechnologies Limited - Charges

Every charge - open or closed - that lenders have registered against Icrest Biotechnologies Limited, with the most recent activity at the to…

2008-09-17 Bangalore, Karnataka Active Unlisted Active Compliant
Share
Connect MCP
IB Icrest Biotechnologies Limited
Open charges
1
68.53 Lakh
Closed charges
2
27.65 Lakh
Total
3
96.18 Lakh
Open vs closed
Top charge holders (by amount)
Top lenders
#LenderChargesAmount
1 Hdfc Bank Limited 1 68.53 Lakh
2 Corporation Bank 1 24.00 Lakh
3 Icici Bank Limited 1 3.65 Lakh
All charges (3) - latest first
Charge ID Charge holder Created Modified Satisfied Amount Status
101016493 Hdfc Bank Limited 24 Oct 2024 - - 68.53 Lakh Open
10619056 Icici Bank Limited 05 Dec 2015 - 28 Jan 2019 3.65 Lakh Closed
10473800 Corporation Bank 31 Dec 2013 - 09 Dec 2015 24.00 Lakh Closed
Frequently Asked Questions - Charges & borrowings
What do "charges" mean for Icrest Biotechnologies Limited?
Charges are registrable security interests-typically loans or credit facilities-filed with MCA against Icrest Biotechnologies Limited (CIN: U33100KA2008PLC047800). They indicate assets or undertakings pledged to lenders or charge holders.
What is the difference between open and closed charges?
Open charges are active or not yet fully discharged; closed (or satisfied) charges are recorded as settled or released. Counts and amounts on this page follow the statuses shown in the charge list.
How should I read the open vs closed amounts?
Open and closed amounts summarise registrable amounts by status for quick comparison; individual rows may show charge-specific amounts, holders, and dates for verification.
Who are the "top lenders" or charge holders?
Top lenders group charge holders by bank or institution name and approximate exposure so you can see which lenders appear most prominently for Icrest Biotechnologies Limited.
Where can I cross-check financial or ownership context?
Pair this Charges view with the Financial and Ownership sections on this company's V1 profile for loans in financial statements and cap table context alongside MCA charge filings.